Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sciety is a venture capital firm founded in 2016, headquartered in Stockholm, Sweden. The organization focuses on investing in pioneering life science companies that have the potential to significantly impact healthcare. Sciety operates primarily in the Nordic region, emphasizing long-term partnerships with unlisted growth companies in the life science and health tech sectors.
Since its inception, Sciety has backed a total of 31 companies, with a notable track record of 9 successful exits, including acquisitions and public listings. The firm combines scientific expertise with investment discipline, positioning itself as a leading investment company in the Nordic life science space. Sciety also operates the Sciety Venture Partners network, which connects experienced investors with life science companies, enhancing collaboration and co-investment opportunities.
Sciety specializes in investments within the life science and health tech sectors, focusing on unlisted growth companies that develop scalable solutions to medical challenges. The firm leads financing rounds typically ranging from SEK 50 million to SEK 200 million (approximately $5 million to $20 million USD). Sciety's investment strategy emphasizes companies with clear clinical needs and strong commercial potential, primarily in the Nordic region.
The organization actively seeks to enhance collaboration among researchers and institutions, aiming to improve the dissemination of research findings. Sciety's investment thesis centers on fostering innovation in scientific research, which aligns with its commitment to advancing healthcare solutions through strategic investments.
Sciety has built a diverse portfolio of 31 companies, focusing on innovative solutions in the life sciences. Notable portfolio companies include:
Sciety's portfolio reflects its commitment to advancing healthcare through innovative technologies and solutions.
Andreas Lindblom: Co-founder & Managing Partner. He has a background in physics and business, with extensive experience in investment and management within the life sciences sector.
Malin Härdig: Co-founder & Managing Partner. She brings expertise in business development and healthcare, contributing to Sciety's strategic direction and investment decisions.
Erik Hjelmstedt: CFO at Kry, previously involved in financial management and strategic planning in healthcare companies.
Gunnar Ahlberg: CEO at GHP Kirurgkliniken at Sophiahemmet, with a strong background in clinical practice and healthcare management.
Founders can pitch to Sciety through their website. It is essential to include a comprehensive business plan, market analysis, and details about the team and technology. Sciety values thoroughness and clarity in presentations. The firm typically responds within a few weeks, and while warm introductions are appreciated, they are not mandatory.
Sciety operates the Sciety Venture Partners network, which connects experienced investors with life science companies. This network facilitates co-investment opportunities and enhances collaboration among portfolio companies. Sciety also leads financing rounds for various companies, such as the SEK 40 million round for Hälsa Hemma and the SEK 87 million round for Neogap Therapeutics.
In March 2026, Sciety's portfolio company Capitainer secured a SEK 30 million follow-on investment led by We Venture Capital. This investment highlights Sciety's active role in supporting its portfolio companies.
Since its founding in 2016, Sciety has invested a total of 1.3 billion SEK across 31 companies, demonstrating its commitment to the life science sector. The firm has achieved 9 successful exits, including acquisitions and public listings, showcasing its strong track record in the industry.
What are Sciety's investment criteria?
Sciety invests in unlisted growth companies within the life science and health tech sectors, focusing on those that develop scalable solutions to medical challenges. The firm looks for companies with clear clinical needs and strong commercial potential.
How can I pitch to Sciety?
Founders can pitch to Sciety through their website. It is advisable to include a detailed business plan, market analysis, and information on the team and technology. Sciety values clarity and thoroughness in pitches.
What makes Sciety different from other investors?
Sciety combines scientific expertise with investment discipline, focusing exclusively on the life science sector. The firm leads financing rounds and actively participates in the growth of its portfolio companies, rather than following other investors.
What is Sciety's geographic focus?
Sciety primarily invests in the Nordic region, targeting companies that are based or operate within this geography.
What is the typical check size for investments?
Sciety typically leads rounds with investments ranging from SEK 50 million to SEK 200 million (approximately $5 million to $20 million USD), deploying its own capital alongside co-investors.
What kind of post-investment support does Sciety provide?
Sciety engages actively with its portfolio companies, providing operational support, strategic guidance, and access to its network of experienced investors through the Sciety Venture Partners network.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.